z-logo
Premium
Solid‐phase peptide synthesis by ion‐paired α‐chymotrypsin in nonaqueous media
Author(s) -
Altreuter David H.,
Dordick Jonathan S.,
Clark Douglas S.
Publication year - 2003
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.10536
Subject(s) - tetrahydrofuran , chemistry , solvent , solubility , phase (matter) , chymotrypsin , chromatography , analytical chemistry (journal) , organic chemistry , enzyme , trypsin
Abstract Solid‐phase synthesis of dipeptides in low‐water media was achieved using AOT ion‐paired α‐chymotrypsin solubilized in organic solvents. Multiple solvents and systematic variation of water activity, a w , were used to examine the rate of coupling between N‐α‐benzyloxycarbonyl‐ L ‐phenylalanine methyl ester (Z‐Phe‐OMe) and leucine as a function of the reaction medium for both solid‐phase and solution‐phase reactions. In solution, the observed maximum reaction rate in a given solvent generally correlated with measures of hydrophobicity such as the log of the 1‐octanol/water partitioning coefficient (log P) and the Hildebrand solubility parameter. The maximum rate for solution‐phase synthesis (13 mmol/h g‐enzyme) was obtained in a 90/10 (v/v) isooctane/tetrahydrofuran solvent mixture at an a w of 0.30. For the synthesis of dipeptides from solid‐phase leucine residues, the highest synthetic rates (0.14–1.3 mmol/h g‐enzyme) were confined to solvent environments that fell inside abruptly defined regions of solvent parameter space (e.g., log P > 2.3 and normalized electron acceptance index <0.13). The maximum rate for solid‐phase synthesis was obtained in a 90/10 (v/v) isooctane/tetrahydrofuran solvent mixture at an a w of 0.14. In 90/10 and 70/30 (v/v) isooctane/tetrahydrofuran environments with a w set to 0.14, seven different N‐protected dipeptides were synthesized on commercially available Tentagel support with yields of 74–98% in 24 h. © 2003 Wiley Periodicals, Inc. Biotechnol Bioeng 81: 809–817, 2003.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here